As Yeti, powers higher, take your profits from my previous idea and consider this new one.
Insurance companies would have their claws in any potential new healthcare law so deep, the law will have slash marks on it.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Negative political pressure is being felt in an overbearing way on the entire healthcare sector.
The stock moves slowly, but tends to do so in one direction.
If I had a bias for SKX it would be on the long side.
What you want to know is what to do with the stocks.
China reported positive data, bolstering markets. Netflix had a beat on earnings, but faces fierce competition ahead. CSX is a thing of beauty.
Hitting a double, triple or 4-bagger is an unattainable dream with most well-known, blue-chip stocks. But it's entirely possible with a small-cap, under-followed name.
For aggressive investors seeking to broaden their exposure in the cannabis and CBD space, I view VFF as an opportunity.
JPM's IV is sitting at a 52-week low, while the stock looks pretty strong.
UNH is best in class, but the class has problems.
The risk-reward on a short-dated trade like this is quite favorable.
The biggest challenge is even if JNJ beats and raises guidance, the overhang of litigation could still prevent overzealous trading.
Should the global economic picture improve this stock will pop more than most.
A low-risk countertrend options trade may be worth a look in this name.
There's enough of a current setup, along with recent earnings history, to take a small shot on long volatility with Coca-Cola stock.
Lyft's big selloff has been silly.
Now is the time to buy shares of MSC Industrial, with the stock poised for a rebound after taking a hit.
We now have a setup for the S&P 500 to creep higher over the next couple of days.
I am spying more upside potential in a name that has become the red-headed stepchild of the semiconductor space.
The company has continually reported better-than-expected earnings often with strong revenue, yet the market has sold off the shares.
The way I do that is by using buy-write option strategies.
Probably more important to focus on than the FOMC Minutes on Wednesday, will be the impact of energy prices on headline March CPI.
Now that it is here, what to do now?
Like many other cyber-related companies, VRNS stock has experienced hiccups.
It is likely time to build a long position in GS, but only on my terms.
The EU is on the ropes. The economy there is in flames.
The best approach with HUBS might be to focus on resistance.
Change cannot and will not happen quickly.